Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
about
Nutraceutical use in late-stage cancer.Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adultsReliability of serum and urinary isoflavone estimatesReproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health StudiesGuidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions.Urine accurately reflects circulating isoflavonoids and ascertains compliance during soy intervention.Urinary isoflavonoid excretion as a biomarker of dietary soy intake during two randomized soy trialsThe volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women.Association of estrogen measurements in serum and urine of premenopausal womenApparent bioavailability of isoflavones after intake of liquid and solid soya foodsAbsorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.Analysis of urinary estrogens, their oxidized metabolites, and other endogenous steroids by benchtop orbitrap LCMS versus traditional quadrupole GCMS.Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic riskPreventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overviewUrinary estrogen metabolites during a randomized soy trial.Correlations of urinary phytoestrogen excretion with lifestyle factors and dietary intakes among middle-aged and elderly Chinese womenEquol production changes over time in pre-menopausal women.Effects of Pubertal Exposure to Dietary Soy on Estrogen Receptor Activity in the Breast of Cynomolgus Macaques.Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women.Urinary isoflavonoids and risk of coronary heart diseaseSoy foods and urinary isoprostanes: results from a randomized study in premenopausal womenUrinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women.Dietary isoflavone intake, urinary isoflavone level, and their relationship with metabolic syndrome diagnostic components in korean postmenopausal women.Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: a pilot feeding studyDietary soy effects on mammary gland development during the pubertal transition in nonhuman primates.Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in the Multiethnic Cohort.Equol production changes over time in postmenopausal women.Urine phyto-oestrogen metabolites are not significantly associated with risk of type 2 diabetes: the Singapore Chinese health study.Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors.Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort.Phytoestrogen Concentrations in Human Urine as Biomarkers for Dietary Phytoestrogen Intake in Mexican Women.Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.
P2860
Q27693359-5B7C260E-3281-430E-89E1-9384A710FEE9Q33602189-ED885AE5-5B61-47BE-8C1E-443933E6ECBBQ33669951-8C8669E4-A740-46B3-A8FC-E3AC47D4553AQ33780836-FFD9B56A-D82F-49F8-BC39-BD176860142BQ33849301-85CADBC2-8697-4E0F-AC79-12F7C7703C1BQ34179479-61DC0CDA-3330-4B7A-933B-58EFECA8F0D2Q34488897-98555DB4-5A6F-48C8-A832-740730062F2CQ34667497-9D9A74CB-F61C-416B-BA82-4666D68C5C32Q35627866-E1DCF825-3B5A-4DE1-806A-35A32D484BA1Q35629640-0714B578-4B27-4916-A8B8-5A26EFF35C4BQ35629651-BE2FA491-1963-43C0-9123-6E4FDF520B29Q35643914-8ED66C3D-44B6-4827-80B2-69C872B4C536Q35671503-211FCB51-B26B-4C34-A437-F1D88BF57C54Q35746403-6D0B7CFC-C63D-4F2D-8705-E76CF65A271BQ35757352-CB946401-22F5-42D6-9E4C-21A2064496FFQ35862704-0AD61648-8DB4-4C9F-BF51-8965D40529D8Q35870029-11878981-91EA-4379-B534-8C99E8564D8CQ35967100-984357AE-1722-4641-BE21-56CB403A7F2FQ35992599-B31EB541-4626-4B8F-9DB8-5098DCFC2215Q36301954-59F186C6-D2D0-452E-8A4A-166A75745DA4Q36573832-4729578F-D4BA-41CC-A8A2-86BF9448FC49Q36604298-DBA6DB23-9208-4ED5-A0EB-1617DB5B11C1Q36611044-2EBADA72-4F8B-4757-AF3A-5BCD625D54A3Q36760028-8CFCA4F2-04C4-42EB-8D64-477F467EED75Q37079722-C258E370-6DA9-40A3-8696-388FDE96A575Q37269712-56D3E6FA-3169-4E0B-96E8-AE4C2E6FFAF1Q37512708-D791DB86-1FE1-4827-AE47-84E257221E88Q40868680-F45C3D4D-1730-4EE2-A4A8-2653DBE44DBDQ44778953-067027E6-F218-437F-B4B6-15AA509E47F2Q45213096-6F600B02-8143-4280-9F0E-E728BF9F117AQ47097251-070C9491-AAB9-466A-8F81-0584981A6B18Q48106159-C33D5051-F205-4413-AAB0-0CD695055050
P2860
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@ast
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@en
type
label
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@ast
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@en
prefLabel
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@ast
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@en
P2093
P2860
P356
P1476
Phytoestrogenic isoflavonoids in epidemiologic and clinical research.
@en
P2093
Adrian A Franke
Brunhild M Halm
Kerry Kakazu
Laurie J Custer
Xingnan Li
P2860
P356
10.1002/DTA.12
P577
2009-01-01T00:00:00Z